Our Mission

The Jane Coffin Childs Memorial Fund for Medical Research is dedicated to providing financial support to offer highly qualified scientists the opportunity to pursue research into the causes and origins of cancer.

The goal of the Fund is to provide support to the brightest individual scientists pursuing careers in cancer research while promoting and emphasizing the value and contribution of the individual in keeping with the spirit of the conception of the Fund.

FINANCIAL REPORTS

2008 FINANCIAL REPORT >
2007 FINANCIAL REPORT >

JCC FUND NEWSLETTERS
Check out our current and past newletters to find out about the newest JCCF fellows and what they are researching, details on our annual retreats, and other interesting articles.

2011 JCC FUND NEWSLETTER >

2010 JCC FUND NEWSLETTER >
2009 JCC FUND NEWSLETTER >
2008 JCC FUND NEWSLETTER >
2007 JCC FUND NEWSLETTER >
2006 JCC FUND NEWSLETTER >
2005 JCC FUND NEWSLETTER >

We will accept referee and sponsor letters either through the website or by email until February 28. Referees may send letters and ratings (from A to E) directly to us at letters@jccfund.org. Sponsor letters may also be sent to the same address. Please paste the contents of your letter inside the body of your email.

Jennifer Schmidt

Nov. 15, 2010

Jennifer Schmidt

A Classic Case of Serendipity

What appeals most to former JCCF Fellow Jennifer Schmidt about academic science are the many facets of the work, especially teaching and having the intellectual freedom to explore different questions. While continuing the genomic imprinting work she started during her 1996-2000 post-doc with Princeton’s Shirley Tilghman, it’s only one of four research areas going on in her lab today at The University of Illinois at Chicago. “I have always had diverse interests,” says Schmidt, after summarizing how she came to study the reproductive genetics of whale sharks, “although I’m a molecular geneticist at heart. That’s the common theme in all of our work.”

Keeping every project moving forward, Schmidt says that the most promising project at present is a mouse model for congenital hydrocephalus. A poorly understood disease, hydrocephalus occurs in about 1 in 500 children and leads to increasing neuronal loss, disability, and death. Schmidt developed the model for hydrocephalus while trying to map the regulatory elements of the imprinted Dlk1 gene. “The Dlk1 experiment actually failed,” Schmidt recalls, “as the best serendipitous experiments often do.”

“We created, unintentionally, a very good enhancer trap in the mouse,” says Schmidt, “and our transgene inserted directly into the center of an unstudied gene that appears to be involved in brain development and is important for fluid balance within the brain,” disrupting the endogenous gene’s function. “All the mice that have the transgene in that location go on to develop hydrocephalus as quite young animals.  It’s an ideal model for studying human hydrocephalus,” says Schmidt, who is now talking with clinicians about the project: “So we didn’t start out to study hydrocephalus, but now we have the possibility to make a big impact on human health.  It’s a classic case of serendipity.”

< NEWS LISTING
Copyright © 2012 The Jane Coffin Childs Memorial Fund for Medical Research. All Rights Reserved
Privacy Policy | Sitemap | Contact Us
This site is best viewed with the latest versions of the following browsers: Safari, Firefox, Google Chrome.
Design by Elements Maintained by Suuch Solutions